Eczema Treatment: Evidence-Based Options for Every Severity

Understanding Eczema Treatment: Why One Size Does Not Fit All

Eczema is not a single disease. It is a group of chronic inflammatory skin conditions that share common features: intense itch, a damaged skin barrier, and immune dysregulation.^[4] Because the root causes of eczema vary from person to person, no single treatment works for everyone. Your eczema type, severity, body location, and age all shape which therapies will help you most.

International guidelines now recommend a stepwise treatment approach. You start with the least aggressive options and escalate only when needed.^[3] This protects you from unnecessary side effects while keeping stronger tools available for tougher flares. Understanding the different types of eczema helps you target the right step from the start.

The Three Pillars of Eczema Management

Effective eczema treatment rests on three pillars. Most failed treatment plans neglect at least one of them.

• Inflammation control: Calming the overactive immune response that drives redness, swelling, and itch. Topical steroids, calcineurin inhibitors, and biologics all target this pillar.^[5]
• Skin barrier repair: Restoring the damaged outer layer that lets moisture escape and irritants enter. Transepidermal water loss (TEWL) can increase two to five times in eczema-affected skin compared to healthy skin.^[6] Understanding why your skin barrier keeps failing can help you choose the right repair strategy.
• Microbiome support: Rebalancing the skin's microbial community. Eczema skin is often dominated by Staphylococcus aureus, which worsens inflammation and disrupts barrier function.^[7]

When you address all three pillars together, each one reinforces the others. A repaired barrier supports a healthier microbiome. A balanced microbiome reduces inflammation. Lower inflammation lets the barrier heal faster. To understand how the microbiome fits into this picture, see our guide on what the skin microbiome is and why it matters.

Matching Treatment to Severity

Dermatologists classify eczema severity as mild, moderate, or severe based on body surface area affected, itch intensity, and impact on sleep and daily life.^[8] Your severity level determines your starting point on the treatment ladder.

Mild eczema often responds to moisturizers and short courses of low-potency topical steroids.^[3] Moderate eczema typically requires prescription topicals or combination OTC approaches. Severe eczema may demand systemic therapies, biologics, or phototherapy. But here is the key: foundational care with moisturizers applies at every severity level.

Foundational Care: Moisturizers and Emollients

Moisturizing is the one step that every eczema treatment plan shares. Regular emollient use reduces flare frequency by approximately 50% and extends the time between flares.^[4] Yet moisturizers alone rarely control active eczema. Think of them as the foundation of a house: essential, but not the whole structure.

Your skin barrier relies on a mix of ceramides, cholesterol, and fatty acids arranged in precise layers. In eczema, this lipid matrix is disrupted, often due to filaggrin gene mutations that affect up to 30% of atopic dermatitis patients.^[9] The result is a barrier that leaks moisture and lets allergens, bacteria, and irritants penetrate more easily.

Choosing the Right Moisturizer Vehicle

Not all moisturizers deliver the same level of protection. The vehicle, meaning the base formulation, matters as much as the active ingredients.

• Ointments (e.g., petroleum jelly): Highest occlusive power. They trap moisture effectively but feel greasy. Best for very dry, thick plaques and nighttime use.^[10]
• Creams: Balance between moisture retention and cosmetic feel. Most patients prefer creams for daytime use. Ceramide-containing creams can help restore the lipid barrier.^[11]
• Lotions: Lightest vehicle with the least occlusive effect. Convenient for large body areas but may not provide enough protection for active eczema.

Fragrance-free formulations are critical. Fragrances are among the most common contact allergens and can trigger or worsen eczema flares.^[12] When choosing a moisturizer for eczema, always check for fragrance, dye, and common preservative allergens on the label. Our guide to the worst ingredients for eczema helps you decode product labels quickly.

The practical takeaway: Apply your moisturizer at least twice daily, and always within three minutes of bathing to lock in hydration.^[13]

The Soak-and-Seal Method

The soak-and-seal technique amplifies your moisturizer's effect. You soak in lukewarm water for 10 to 15 minutes, gently pat skin until slightly damp, then immediately apply your moisturizer or prescribed topical to seal in the water.^[13] This method can significantly improve skin hydration and reduce TEWL.^[13]

For severe flares, your doctor may recommend taking this concept further with wet wrap therapy, which adds a layer of damp fabric over the moisturizer to boost absorption. But even the basic soak-and-seal routine can make a noticeable difference in daily comfort.

Topical Prescription Treatments

When moisturizers alone cannot control your eczema, topical prescription treatments become the next step. These medications target inflammation directly at the skin surface. Several classes are available, each with distinct mechanisms and safety profiles.

Topical Corticosteroids: Potency and Safety

Topical corticosteroids remain the first-line anti-inflammatory treatment for eczema flares. They work by suppressing the local immune response and reducing redness, swelling, and itch.^[5] Potency ranges from Class VII (mildest, such as 1% hydrocortisone) to Class I (superpotent, such as clobetasol propionate 0.05%).^[14]

The right potency depends on your flare severity and body location. Thin-skinned areas like the face, eyelids, and groin require low-potency steroids to avoid skin thinning (atrophy). Thicker skin on palms and soles may need higher potency to penetrate effectively.^[14] For guidance on sensitive areas, see our facial eczema treatment guide.

Non-Steroidal Prescription Topicals

Several non-steroidal options now give you and your doctor alternatives, especially for sensitive areas or long-term maintenance.

Tacrolimus and pimecrolimus do not cause skin thinning, making them valuable for long-term use on the face and other sensitive areas.^[17] Crisaborole received approval for patients as young as 3 months, expanding options for very young children.^[18] Ruxolitinib cream showed significant itch reduction within 12 hours in clinical trials, faster than most other topicals.^[19]

These newer options cost more than generic steroids. But for patients who need long-term topical eczema treatment without steroid risks, they fill a critical gap. Your dermatologist can help you weigh the trade-offs. For a deeper look at the full range of prescription options, see our guide to atopic dermatitis treatments from topicals to biologics.

Over-the-Counter Treatment Options

Walk into any pharmacy and you will find dozens of products claiming to help eczema. The problem is that they all look the same on the shelf. In reality, OTC eczema treatments fall into four distinct categories, and each one addresses a different piece of the puzzle.

Understanding these categories helps you stop guessing and start choosing based on what your skin actually needs.

OTC Moisturizers and Prebiotic Moisturizers

Category 1: Plain OTC Moisturizers. These include petroleum jelly, ceramide creams, and basic emollients. They address the barrier repair pillar by reducing TEWL and protecting the skin surface.^[10] What they miss: they provide no anti-inflammatory action and do not support the skin microbiome. For active, inflamed eczema, moisturizers alone are not enough.

Category 2: Prebiotic Moisturizers. These newer formulations add ingredients designed to support beneficial skin bacteria while still providing barrier repair. Early research suggests that microbiome-targeted moisturizers may help reduce S. aureus colonization and support microbial diversity on eczema skin.^[20] They address two pillars (barrier and microbiome) but still lack direct anti-inflammatory action.

For help choosing between these options, our guide on which cream is good for eczema breaks down the science behind specific ingredients.

OTC Anti-Inflammatories and SmartLotion

Category 3: OTC Anti-Inflammatories. The main option here is 1% hydrocortisone, the only OTC steroid available without a prescription. It provides mild anti-inflammatory relief for minor eczema rashes. However, 1% hydrocortisone is the weakest steroid class (Class VII) and often proves insufficient for anything beyond the mildest flares. It also does nothing for barrier repair or microbiome balance, and prolonged unsupervised use on the face or skin folds carries risks.

Category 4: All-in-One Prebiotic Anti-Inflammatory Formulations. HarlanMD represents this category with an effective eczema cream that combines a low-dose anti-inflammatory with prebiotic ingredients designed to support the skin microbiome. By addressing inflammation and microbiome balance in a single OTC formulation, it targets two of the three treatment pillars simultaneously.

For detailed usage instructions, see the SmartLotion protocol for atopic dermatitis.

Systemic Therapies and Biologics for Moderate to Severe Eczema

When topical treatments and OTC options cannot control your eczema, systemic therapies work from the inside out. These medications travel through your bloodstream to calm the immune system body-wide. They represent a major step up in both effectiveness and monitoring requirements.

Biologic Therapies

Biologics are engineered proteins that target specific immune pathways driving eczema inflammation.

• Dupilumab: Blocks interleukin-4 and interleukin-13, two key cytokines in atopic dermatitis. In pivotal trials, approximately 40% of patients achieved EASI-75 (75% skin clearance) at 16 weeks.^[5] Approved for patients aged 6 months and older.^[21]
• Tralokinumab: Specifically targets IL-13 alone. Clinical trials showed EASI-75 response rates of approximately 40% as monotherapy at 16 weeks, with higher rates (approximately 58%) when combined with topical steroids.^[22]

Oral JAK Inhibitors and Immunosuppressants

Oral JAK inhibitors represent the newest class of systemic eczema treatment. They block Janus kinase enzymes inside immune cells, interrupting multiple inflammatory signals at once.^[24]

• Upadacitinib: Achieved EASI-75 in up to 70% of patients at 16 weeks in clinical trials, making it one of the most effective oral options.^[24]
• Abrocitinib: Showed EASI-75 rates of approximately 40–60% depending on dose, with rapid itch improvement.^[25]
• Baricitinib: Approved in some regions for moderate-to-severe AD, with more modest efficacy but a favorable safety profile in trials.^[26]

Doctors still use traditional immunosuppressants like cyclosporine, methotrexate, and azathioprine when biologics and JAK inhibitors are unavailable or contraindicated. However, they carry broader immunosuppressive effects and require regular blood monitoring.^[27]

Phototherapy and Procedural Treatments

Phototherapy uses controlled ultraviolet light to calm the immune response in your skin. Narrowband UVB (NB-UVB) is the most commonly used form and can achieve good-to-excellent improvement in 60–70% of eczema patients.^[28] For a full overview of how phototherapy fits into the treatment ladder, see our guide to atopic dermatitis treatments from topicals to biologics.

A typical course involves two to three sessions per week for 12 to 16 weeks. Each session lasts only minutes. The time commitment of traveling to a clinic multiple times weekly can be a barrier for many patients.^[28] Home phototherapy units are available by prescription and can improve adherence for those who qualify.

PUVA therapy (psoralen plus UVA light) is an older option reserved for cases that do not respond to NB-UVB. It carries a higher risk of long-term skin damage and is used less frequently today.^[29]

For acute severe flares, wet wrap therapy offers a procedural approach that can rapidly reduce inflammation. Studies show wet wraps with dilute topical steroids can produce significant improvement within days during hospitalization or intensive outpatient care.^[30]

Natural and Complementary Approaches

Many people with eczema seek natural treatments, especially after frustration with conventional options. Some natural approaches have genuine evidence behind them. Others carry risks that "natural" branding obscures. The distinction matters. Understanding what causes eczema flare-ups can help you evaluate whether a natural remedy is targeting a real trigger or simply a trend.

What the Evidence Supports

• Colloidal oatmeal: Contains avenanthramides with anti-inflammatory and anti-itch properties. Clinical studies show it can improve skin barrier function and reduce itch severity when used as a bath additive or in moisturizers.^[31]
• Coconut oil: Demonstrates both emollient and antimicrobial effects. Laboratory studies show virgin coconut oil inhibits S. aureus growth and damages bacterial cell walls, supporting its antimicrobial properties.^[32]
• Vitamin D supplementation: Meta-analyses suggest that vitamin D supplementation may modestly reduce eczema severity, particularly in patients with low baseline vitamin D levels.^[33] For more on this topic, see our article on whether vitamins can help eczema.
• Oral probiotics: Evidence for probiotic prevention of eczema is highly strain-specific. A 2018 meta-analysis of five RCTs found that Lactobacillus rhamnosus GG (LGG) did not significantly reduce eczema risk in high-risk infants regardless of timing of administration (RR 0.90, 95% CI 0.67–1.21).^[34] Evidence for treating established eczema remains weak across most strains.

What to Approach with Caution

• Tea tree oil: Has antimicrobial properties but is a known contact allergen. It can cause irritant or allergic contact dermatitis, especially on already-compromised eczema skin.^[35]
• Apple cider vinegar: Sometimes promoted for its acidic pH, but clinical evidence is limited. One small trial found no significant benefit over placebo, and some participants reported skin irritation and burning.^[36]
• Essential oils: Most essential oils are concentrated plant extracts with high allergenic potential. They can worsen eczema through contact sensitization.

Here's the bottom line: "Natural" does not mean safe for eczema skin. Always patch-test new products and discuss complementary approaches with your doctor.

For parents exploring gentle options, our guide to the best natural eczema cream for babies evaluates what the evidence actually supports for young children.

Eczema Treatment by Special Population

Eczema treatment is not one-size-fits-all, and certain populations need specific considerations. What works for an adult with hand eczema may be inappropriate for a newborn with facial eczema. Body location and age both change the safety and effectiveness equation.

Treating Eczema in Infants and Newborns

Eczema treatment for newborns and infants requires extra caution. Infant skin is thinner and absorbs topical medications more readily. The higher surface-area-to-body-weight ratio increases the risk of systemic absorption.^[37] For a deeper look at why babies develop eczema in the first place, see our guide on what causes eczema in babies.

• First-line: Frequent emollient application (fragrance-free, dye-free) is the cornerstone of infant eczema management. However, the large BEEP RCT (n=1,394) found that daily emollient from birth did not prevent eczema in high-risk infants and was associated with more skin infections.^[38] Emollients remain essential for treating active eczema and maintaining skin comfort.
• Mild flares: Low-potency topical steroids (1% hydrocortisone) for short courses under medical supervision.^[37]
• Steroid-sparing options: Crisaborole is approved for infants 3 months and older. Pimecrolimus is approved for children 2 years and older.^[18][17]

For a complete approach to infant eczema, see our evidence-based baby eczema treatment guide.

Contact Dermatitis and Location-Specific Treatment

Contact eczema treatment differs from atopic dermatitis management in one critical way: you must identify and remove the trigger. Patch testing can identify the specific allergen causing your reaction, and avoidance is the most effective long-term strategy.^[39] Learn more about irritant contact dermatitis and how it differs from allergic reactions. For contact dermatitis protocols, see the contact dermatitis treatment guide.

Head eczema treatment and scalp eczema require formulations suited to hair-bearing skin. Medicated shampoos containing ketoconazole or coal tar can help when seborrheic dermatitis overlaps with atopic eczema on the scalp.^[40] Scalp-specific steroid solutions and foams penetrate better than creams in this area. Our eczema scalp treatment guide covers these options in detail.

Hand eczema is notoriously stubborn because hands face constant exposure to water, soap, and irritants. Treatment often requires potent topical steroids, barrier creams, and strict irritant avoidance.^[41] Some countries have approved alitretinoin, an oral retinoid, for severe chronic hand eczema that does not respond to potent topical steroids.^[41] Learn more in our guide on why your hand eczema will not heal.

Building Your Eczema Treatment Plan

The most effective eczema treatment plans combine multiple approaches rather than relying on a single product or medication. Research consistently shows that combination therapy outperforms monotherapy for eczema management.^[42] For guidance on how diet fits into your overall plan, see our article on diet and eczema.

Notice that foundational moisturizing care appears at every severity level. It never becomes optional. The anti-inflammatory and additional options escalate as severity increases, but the base stays the same.

When to See a Dermatologist

See a dermatologist if your eczema does not improve after two weeks of consistent OTC treatment. You should also seek care if it covers large areas of your body, disrupts your sleep, or shows signs of infection such as oozing, crusting, or increased pain.^[43] If nighttime itching is disrupting your rest, our guide on sleeping with eczema offers targeted strategies.

A dermatologist can confirm your diagnosis, rule out other conditions, and build a personalized treatment ladder. For a broader set of management strategies, see our guide on how to tackle eczema safely with 12 evidence-based strategies.

Frequently Asked Questions About Eczema Treatment

What Helps Heal Eczema Fast?

The fastest way to calm an eczema flare is to combine a medium-potency topical corticosteroid with intensive moisturizing using the soak-and-seal method. Applying your steroid to damp skin after bathing improves penetration and can produce visible improvement within days.^[13] For severe flares, wet wrap therapy can accelerate results further.^[30] However, "fast" and "lasting" are different goals. Long-term control requires consistent daily care, not just flare treatment. For a structured approach to daily management, see our guide on bad habits that make eczema worse.

What Is the 3 Minute Rule for Eczema?

The 3 minute rule means applying your moisturizer within three minutes of bathing, while your skin is still slightly damp. This traps the water your skin absorbed during the bath and seals it in with the emollient layer.^[13] Waiting longer allows that moisture to evaporate, reducing the benefit of your moisturizer significantly.^[13]

Can Eczema Be Cured Permanently?

There is currently no permanent cure for eczema. However, many children with atopic dermatitis experience significant improvement or complete remission by adulthood, though remission rates vary by disease severity and study population. For adults, the goal is long-term management that minimizes flares and maintains quality of life.

Which Cream Is Best for Eczema?

The best cream depends on your eczema severity and what your skin needs. For basic maintenance, a fragrance-free ceramide cream repairs the barrier. For active flares, you need an anti-inflammatory component, whether that is a prescription topical steroid, a calcineurin inhibitor, or an OTC option like SmartLotion that combines anti-inflammatory, prebiotic, and moisturizing action in a single formulation. Our science-backed cream guide helps you match the right product to your situation.

Is Eczema Treatment Different for Children?

Yes. Children, especially infants, have thinner skin that absorbs topical medications more readily.^[37] This means lower-potency steroids, shorter treatment courses, and closer monitoring are standard. Some newer medications like crisaborole are specifically approved for very young children.^[18] Emollient therapy is even more important in pediatric eczema because it can reduce the need for prescription treatments. See our baby eczema treatment guide for age-specific recommendations.

Is There an OTC Eczema Treatment That Addresses All Three Pillars?

Most OTC products target only one or two of the three eczema treatment pillars (barrier repair, inflammation control, microbiome support). Plain moisturizers repair the barrier. Standard 1% hydrocortisone provides mild anti-inflammatory action but no barrier or microbiome benefit. SmartLotion is the only OTC formulation that addresses all three pillars in one product, combining low-dose hydrocortisone (0.75%) with prebiotic ingredients and built-in moisturization. It is safe for all body areas, all ages, and all severity levels, with a 30+ year clinical track record supporting long-term daily use.^[44]

References

1. Deckers IAG, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. "Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies." PLoS One. 2012. View Study
2. Simpson EL, Guttman-Yassky E, Margolis DJ, et al. "Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis." JAMA Dermatology. 2018. View Study
3. Lugović-Mihić L, Barac E, Tomašević R, Parać E, Zanze L, Ljevar A, Dolački L, Štrajtenberger M. "Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review." Pharmaceuticals (Basel). 2024. View Study
4. Boguniewicz M, Leung DYM. "Atopic Dermatitis: A Disease of Altered Skin Barrier and Immune Dysregulation." Immunological Reviews. 2011. View Study
5. Subramaniam P, Shafiee MN, Md Fadilah NI, Fauzi MB, Maarof M. "Secretome as a novel regenerative strategy for atopic dermatitis: a comprehensive review." Stem Cell Research & Therapy. 2026. View Study
6. Montero-Vilchez T, Segura-Fernández-Nogueras MV, Pérez-Rodríguez I, Soler-Gongora M, Martinez-Lopez A, Fernández-González A, Molina-Leyva A, Arias-Santiago S. "Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity." Journal of Clinical Medicine. 2021. View Study
7. Ćorović M, Petrov Ivanković A, Milivojević A, Pfeffer K, Homey B, Jansen PAM, Zeeuwen PLJM, van den Bogaard EH, Bezbradica D. "Investigating the Effect of Enzymatically-Derived Blackcurrant Extract on Skin Staphylococci Using an In Vitro Human Stratum Corneum Model." Pharmaceutics. 2025. View Study
8. Silverberg JI, Lei D, Yousaf M, et al. "Measurement properties of the product of investigator's global assessment and body surface area in children and adults with atopic dermatitis." Journal of the European Academy of Dermatology and Venereology. 2021. View Study
9. Brown SJ. "Atopic eczema." Clinical Medicine (London, England). 2016. View Study
10. Rüther L, Voss W. "Hydrogel or ointment? Comparison of five different galenics regarding tissue breathability and transepidermal water loss." Heliyon. 2021. View Study
11. Wang D-Q, Li X, Zhang R-Y, Yuan C, Yan B, Humbert P, Quan Z-X. "Effects of Investigational Moisturizers on the Skin Barrier and Microbiome following Exposure to Environmental Aggressors: A Randomized Clinical Trial and Ex Vivo Analysis." Journal of Clinical Medicine. 2023. View Study
12. Owen JL, Vakharia PP, Silverberg JI. "The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis." American Journal of Clinical Dermatology. 2018. View Study
13. Chiang C, Eichenfield LF. "Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis." Pediatric Dermatology. 2009. View Study
14. Bowie AC, Tadrous M, Egeberg A, Harvey J, Lax SJ, Thyssen JP, Drucker AM. "Agreement and Correlation Between Different Topical Corticosteroid Potency Classification Systems." JAMA Dermatology. 2022. View Study
15. Abe M, Igarashi A, Kitajima H, Toyama H, Kabashima K, Saeki H. "Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis." The Journal of Dermatology. 2025. View Study
16. Matsuki F, Suzuki S, Hirose T, Suzuki T, Yoshida T, Onishi Y, Yamamoto R. "Prescription and application adequacy of topical corticosteroids based on the finger-tip unit method in adult patients with atopic dermatitis: A cross-sectional study." Journal of General and Family Medicine. 2025. View Study
17. Davari DR, Nieman EL, McShane DB, Morrell DS. "Current Perspectives on the Management of Infantile Atopic Dermatitis." Journal of Asthma and Allergy. 2020. View Study
18. Schlessinger J, Shepard JS, Gower R, Su JC, Lynde C, Cha A, et al. "Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to <24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)." American Journal of Clinical Dermatology. 2020. View Study
19. Simpson EL, Augustin M, Thaçi D, Misery L, Armstrong AW, Blauvelt A, Papp KA, Szepietowski JC, Boguniewicz M, Kwatra SG, Kallender H, Sturm D, Ren H, Kircik L. "Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies." American Journal of Clinical Dermatology. 2025. View Study
20. Liu-Walsh F, Tierney NK, Hauschild J, Rush AK, Masucci J, Leo GC, Capone KA. "Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid." Clinical, Cosmetic and Investigational Dermatology. 2021. View Study
21. Cork MJ, Thaçi D, Eichenfield LF, Arkwright PD, Chen Z, Thomas RB, Kosloski MP, Dubost-Brama A, Prescilla R, Bansal A, Levit NA. "Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis." Dermatology and Therapy. 2023. View Study
22. Blauvelt A, Gooderham M, Bhatia N, et al. "Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3." Dermatology and Therapy. 2022. View Study
23. Ferrucci S, Casazza G, Angileri L, Tavecchio S, Germiniasi F, Berti E, Marzano AV, Genovese G. "Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience." Journal of Clinical Medicine. 2020. View Study
24. Blauvelt A, Teixeira HD, Simpson EL, et al. "Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial." JAMA Dermatology. 2022. View Study
25. Armstrong AW, Alexis AF, Blauvelt A, Silverberg JI, Feeney C, Levenberg M, Chan G, Zhang F, Fostvedt L. "Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis." Dermatology and Therapy. 2024. View Study
26. Radi G, Simonetti O, Rizzetto G, Diotallevi F, Molinelli E, Offidani A. "Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients." Healthcare (Basel). 2021. View Study
27. Yim HJ, Jean T, Ong PY. "Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis." Current Allergy and Asthma Reports. 2024. View Study
28. Molla A. "A Comprehensive Review of Phototherapy in Atopic Dermatitis: Mechanisms, Modalities, and Clinical Efficacy." Cureus. 2024. View Study
29. Musters AH, Mashayekhi S, Harvey J, et al. "Phototherapy for atopic eczema." Cochrane Database of Systematic Reviews. 2021. View Study
30. Hindley D, Galloway G, Murray J, Gardener L. "A randomised study of 'wet wraps' versus conventional treatment for atopic eczema." Archives of Disease in Childhood. 2006. View Study
31. Park J, Shin JY, Kim D, Jun S-H, Jeong ET, Kang N-G. "Dihydroavenanthramide D Enhances Skin Barrier Function through Upregulation of Epidermal Tight Junction Expression." Current Issues in Molecular Biology. 2024. View Study
32. Widianingrum DC, Noviandi CT, Salasia SIO. "Antibacterial and immunomodulator activities of virgin coconut oil (VCO) against Staphylococcus aureus." Heliyon. 2019. View Study
33. Nielsen AY, Høj S, Thomsen SF, Meteran H. "Vitamin D Supplementation for Treating Atopic Dermatitis in Children and Adults: A Systematic Review and Meta-Analysis." Nutrients. 2024. View Study
34. Szajewska H, Horvath A. "Lactobacillus rhamnosus GG in the Primary Prevention of Eczema in Children: A Systematic Review and Meta-Analysis." Nutrients. 2018. View Study
35. Kairey L, Agnew T, Bowles EJ, Barkla BJ, Wardle J, Lauche R. "Efficacy and safety of Melaleuca alternifolia (tea tree) oil for human health—A systematic review of randomized controlled trials." Frontiers in Pharmacology. 2023. View Study
36. Luu LA, Flowers RH, Gao Y, Wu M, Gasperino S, Kellams AL, Preston DC, Zlotoff BJ, Wisniewski JA, Zeichner SL. "Apple cider vinegar soaks do not alter the skin bacterial microbiome in atopic dermatitis." PLoS One. 2021. View Study
37. Luger T, Boguniewicz M, Carr W, et al. "Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants." Pediatric Allergy and Immunology. 2015. View Study
38. Bradshaw LE, Wyatt LA, Brown SJ, et al. "Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT." Health Technology Assessment. 2024. View Study
39. Yang YW, Yiannias JA, Voss MM, Hall MR, Youssef MJ, Davis MDP, Voelker DH, Klanderman MC, Mangold AR. "Systematic Identification of Copositivity Groups in Standard Series Patch Testing Through Hierarchical Clustering." JAMA Dermatology. 2023. View Study
40. Tynes BE, Johnson CD, Vaish MH, Abbott B, Vučenović J, Varrassi G, Potharaju P, Lopez Torres Y, Lee Z, Ahmadzadeh S, Shekoohi S, Kaye AD. "Ketoconazole Shampoo for Seborrheic Dermatitis of the Scalp: A Narrative Review." Cureus. 2024. View Study
41. Smith IL, Gilberts R, Brown S, et al. "Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial." BMJ Open. 2022. View Study
42. Zhang Y, Chen Y, Li C. "Study on the clinical efficacy of soothing moisturizing repairing cream combined with desonide in the treatment of atopic dermatitis in children." Medicine (Baltimore). 2025. View Study
43. Egeberg A, Thyssen JP, Wu JJ, Pierce E, Ross Terres JA. "Treatment Patterns in Danish Patients with Atopic Dermatitis Before and After Hospital Referral." Dermatology and Therapy. 2021. View Study
44. Aron R, Aron S. "Hydrocortisone/Sulfur Combination Therapy: A Long-Term Safety Study." The Journal of Clinical and Aesthetic Dermatology. 2008. View Study